These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 9513592

  • 1. (R)-3,N-dimethyl-N-[1-methyl-3-(4-methyl-piperidin-1-yl) propyl]benzenesulfonamide: the first selective 5-HT7 receptor antagonist.
    Forbes IT, Dabbs S, Duckworth DM, Jennings AJ, King FD, Lovell PJ, Brown AM, Collin L, Hagan JJ, Middlemiss DN, Riley GJ, Thomas DR, Upton N.
    J Med Chem; 1998 Feb 26; 41(5):655-7. PubMed ID: 9513592
    [No Abstract] [Full Text] [Related]

  • 2. Functional characterisation of the human cloned 5-HT7 receptor (long form); antagonist profile of SB-258719.
    Thomas DR, Gittins SA, Collin LL, Middlemiss DN, Riley G, Hagan J, Gloger I, Ellis CE, Forbes IT, Brown AM.
    Br J Pharmacol; 1998 Jul 26; 124(6):1300-6. PubMed ID: 9720804
    [Abstract] [Full Text] [Related]

  • 3. Differential inverse agonist efficacies of SB-258719, SB-258741 and SB-269970 at human recombinant serotonin 5-HT7 receptors.
    Mahé C, Loetscher E, Feuerbach D, Müller W, Seiler MP, Schoeffter P.
    Eur J Pharmacol; 2004 Jul 14; 495(2-3):97-102. PubMed ID: 15249157
    [Abstract] [Full Text] [Related]

  • 4. Medicinal chemistry driven approaches toward novel and selective serotonin 5-HT6 receptor ligands.
    Holenz J, Mercè R, Díaz JL, Guitart X, Codony X, Dordal A, Romero G, Torrens A, Mas J, Andaluz B, Hernández S, Monroy X, Sánchez E, Hernández E, Pérez R, Cubí R, Sanfeliu O, Buschmann H.
    J Med Chem; 2005 Mar 24; 48(6):1781-95. PubMed ID: 15771424
    [Abstract] [Full Text] [Related]

  • 5. Design, synthesis, and pharmacological evaluation of piperidin-4-yl amino aryl sulfonamides: novel, potent, selective, orally active, and brain penetrant 5-HT₆ receptor antagonists.
    Nirogi R, Shinde A, Daulatabad A, Kambhampati R, Gudla P, Shaik M, Gampa M, Balasubramaniam S, Gangadasari P, Reballi V, Badange R, Bojja K, Subramanian R, Bhyrapuneni G, Muddana N, Jayarajan P.
    J Med Chem; 2012 Nov 08; 55(21):9255-69. PubMed ID: 23006002
    [Abstract] [Full Text] [Related]

  • 6. N-[(1-butyl-4-piperidinyl)methyl]-3,4dihydro-2H-[1,3]oxazino[3,2- a]indole10-carboxamide hydrochloride: the first potent and selective 5-HT4 receptor antagonist amide with oral activity.
    Gaster LM, Joiner GF, King FD, Wyman PA, Sutton JM, Bingham S, Ellis ES, Sanger GJ, Wardle KA.
    J Med Chem; 1995 Nov 24; 38(24):4760-3. PubMed ID: 7490724
    [No Abstract] [Full Text] [Related]

  • 7. A novel, potent, and selective 5-HT(7) antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl) phen ol (SB-269970).
    Lovell PJ, Bromidge SM, Dabbs S, Duckworth DM, Forbes IT, Jennings AJ, King FD, Middlemiss DN, Rahman SK, Saunders DV, Collin LL, Hagan JJ, Riley GJ, Thomas DR.
    J Med Chem; 2000 Feb 10; 43(3):342-5. PubMed ID: 10669560
    [No Abstract] [Full Text] [Related]

  • 8. Conformationally constrained N1-arylsulfonyltryptamine derivatives as 5-HT6 receptor antagonists.
    Cole DC, Lennox WJ, Stock JR, Ellingboe JW, Mazandarani H, Smith DL, Zhang G, Tawa GJ, Schechter LE.
    Bioorg Med Chem Lett; 2005 Nov 01; 15(21):4780-5. PubMed ID: 16125933
    [Abstract] [Full Text] [Related]

  • 9. Structure-affinity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinealkylamides, a new class of 5-hydroxytryptamine7 receptor agents.
    Leopoldo M, Berardi F, Colabufo NA, Contino M, Lacivita E, Niso M, Perrone R, Tortorella V.
    J Med Chem; 2004 Dec 16; 47(26):6616-24. PubMed ID: 15588097
    [Abstract] [Full Text] [Related]

  • 10. Aryl biphenyl-3-ylmethylpiperazines as 5-HT7 receptor antagonists.
    Kim J, Kim Y, Tae J, Yeom M, Moon B, Huang XP, Roth BL, Lee K, Rhim H, Choo IH, Chong Y, Keum G, Nam G, Choo H.
    ChemMedChem; 2013 Nov 16; 8(11):1855-64. PubMed ID: 24039134
    [Abstract] [Full Text] [Related]

  • 11. Quinolinesulfonamides of aryloxy-/arylthio-ethyl piperidines: influence of an arylether fragment on 5-HT1A/5-HT7 receptor selectivity.
    Grychowska K, Marciniec K, Canale V, Szymiec M, Glanowski G, Satała G, Maślankiewicz A, Pawłowski M, Bojarski AJ, Zajdel P.
    Arch Pharm (Weinheim); 2013 Mar 16; 346(3):180-8. PubMed ID: 23381952
    [Abstract] [Full Text] [Related]

  • 12. 5-HT₂c receptor selectivity and structure-activity relationship of N-methyl-N-(1-methylpiperidin-4-yl)benzenesulfonamide analogs.
    Jang JW, Baek JS, Choi GD, Park WK, Cho YS, Baek DJ, Pae AN.
    Bioorg Med Chem Lett; 2012 Jan 01; 22(1):347-52. PubMed ID: 22153942
    [Abstract] [Full Text] [Related]

  • 13. The multiobjective based design, synthesis and evaluation of the arylsulfonamide/amide derivatives of aryloxyethyl- and arylthioethyl- piperidines and pyrrolidines as a novel class of potent 5-HT₇ receptor antagonists.
    Zajdel P, Kurczab R, Grychowska K, Satała G, Pawłowski M, Bojarski AJ.
    Eur J Med Chem; 2012 Oct 01; 56():348-60. PubMed ID: 22926225
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and biological evaluation of (phenylpiperazinyl-propyl)arylsulfonamides as selective 5-HT(2A) receptor antagonists.
    Yoo E, Yoon J, Pae AN, Rhim H, Park WK, Kong JY, Park Choo HY.
    Bioorg Med Chem; 2010 Feb 15; 18(4):1665-75. PubMed ID: 20096593
    [Abstract] [Full Text] [Related]

  • 15. N'-(arylsulfonyl)pyrazoline-1-carboxamidines as novel, neutral 5-hydroxytryptamine 6 receptor (5-HT₆R) antagonists with unique structural features.
    van Loevezijn A, Venhorst J, Iwema Bakker WI, de Korte CG, de Looff W, Verhoog S, van Wees JW, van Hoeve M, van de Woestijne RP, van der Neut MA, Borst AJ, van Dongen MJ, de Bruin NM, Keizer HG, Kruse CG.
    J Med Chem; 2011 Oct 27; 54(20):7030-54. PubMed ID: 21866910
    [Abstract] [Full Text] [Related]

  • 16. Sulfonamides with the N-alkyl-N'-dialkylguanidine moiety as 5-HT7 receptor ligands.
    Zajdel P, Subra G, Verdie P, Gabzdyl E, Bojarski AJ, Duszyńska B, Martinez J, Pawłowski M.
    Bioorg Med Chem Lett; 2009 Aug 15; 19(16):4827-31. PubMed ID: 19560916
    [Abstract] [Full Text] [Related]

  • 17. N1-arylsulfonyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives are potent and selective 5-HT6 receptor antagonists.
    Cole DC, Ellingboe JW, Lennox WJ, Mazandarani H, Smith DL, Stock JR, Zhang G, Zhou P, Schechter LE.
    Bioorg Med Chem Lett; 2005 Jan 17; 15(2):379-83. PubMed ID: 15603958
    [Abstract] [Full Text] [Related]

  • 18. Bicyclic piperazinylbenzenesulphonamides are potent and selective 5-HT6 receptor antagonists.
    Bromidge SM, Clarke SE, King FD, Lovell PJ, Newman H, Riley G, Routledge C, Serafinowska HT, Smith DR, Thomas DR.
    Bioorg Med Chem Lett; 2002 May 20; 12(10):1357-60. PubMed ID: 11992776
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and pharmacological characterization of novel 6-fluorochroman derivatives as potential 5-HT1A receptor antagonists.
    Yasunaga T, Kimura T, Naito R, Kontani T, Wanibuchi F, Yamashita H, Nomura T, Tsukamoto S, Yamaguchi T, Mase T.
    J Med Chem; 1998 Jul 16; 41(15):2765-78. PubMed ID: 9667967
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and biological evaluation of benzoisothiazole derivatives possessing N,N-dimethylformimidamide group as 5-HT₆ receptor antagonists.
    Yoo E, Hayat F, Rhim H, Park Choo HY.
    Bioorg Med Chem; 2012 Apr 15; 20(8):2707-12. PubMed ID: 22405919
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.